Previsioni di mercato per il trattamento della sarcopenia in Sud e Centro America fino al 2030 - Analisi regionale - per tipo di trattamento (integratore di vitamina D e calcio, integratore proteico, integratore di vitamina B12 e altri) e canale di distribuzione (farmacie, canali di vendita al dettaglio, canali online e altri)
I prodotti nelle fasi di sperimentazione clinica alimentano il mercato del trattamento della sarcopenia in Sud e Centro America
Alcuni dei principali attori che operano nel mercato del trattamento della sarcopenia si stanno concentrando sempre più sullo sviluppo di farmaci per il trattamento della sarcopenia. Nuovi trattamenti per la sarcopenia sono attualmente in fase di sviluppo e testati in studi clinici. Alcuni di questi prodotti sono menzionati di seguito:
Farmaco per la sarcopenia in fase di sviluppo clinico
Nome dell\'azienda
Interventi
Condizioni
Sperimentazione clinica Stage
Abbott Nutrition
Alimenti medici con AN777
Formula nutrizionale orale
Malnutrizione
Sarcopenia
PHASE3 < br>
Nutricia Research
Integratore alimentare: Bolus ONS A
Integratore alimentare: Bolus ONS B
Integratore alimentare: Bolus ONS C
Dietetico Supplemento: Bolus ONS D
Sarcopenia
PHASE1
Novartis Pharmaceuticals
Farmaco: Bimagrumab
Sarcopenia
PHASE2
McMaster University
Comportamentale: riduzione graduale della sarcopenia
PHASE1
Metabolic Technologies Inc.
Integratore alimentare : Placebo
Farmaco: HMB più vitamina D
Comportamentale: mancato esercizio fisico
Comportamentale: esercizio fisico
Sarcopenia
PHASE1
>
Merck Sharp & Dohme LLC
Farmaco: comparatore MK-077
Farmaco: comparatore Placebo
Sarcopenia
FASE2
Immunotec Inc.
Integratore alimentare: Immunocal
Integratore alimentare: Caseina
Invecchiamento e sarcopenia
PHASE2
Lijun Yang
Prodotto combinato: intervento intensivo di 3 mesi
Sarcopenia
PHASE4
Regeneron Pharmaceuticals
Farmaco: REGN1033 (SAR391786)
br>Farmaco: Placebo
Sarcopenia
FASE2
Fonte: siti web aziendali e analisi di Insight Partners
Pertanto, la pipeline in espansione di farmaci che sono in le diverse fasi di sviluppo clinico presentano opportunità significative per la crescita del mercato del trattamento della sarcopenia.
Panoramica del mercato del trattamento della sarcopenia in America meridionale e centrale
Il mercato del trattamento della sarcopenia in America meridionale e centrale è segmentato in Brasile, Argentina e nel resto dell\'America meridionale e centrale. L’aumento della popolazione geriatrica e l’aumento dell’incidenza della carenza vitaminica alimentano il mercato del trattamento della sarcopenia nell’America meridionale e centrale.
L\'introduzione di nuove normative da parte dell\'Agenzia Nazionale di Sorveglianza Sanitaria (ANVISA) per gli integratori alimentari nel 2018 ha reso più facile l\'ingresso di nuovi marchi in Brasile. Inoltre, ha aiutato i marchi esistenti a prosperare e innovare nel Paese. Secondo uno studio pubblicato nella Biblioteca Nazionale di Medicina, la popolazione anziana è in rapida crescita in Brasile, con conseguente aumento della prevalenza di patologie croniche associate alla vecchiaia. La prevalenza complessiva della sarcopenia nella popolazione anziana in Brasile è stata di circa il 20,0% nel 2020. Secondo un articolo pubblicato dal National Institute of Health, nel 2022, la prevalenza della probabile sarcopenia è del 42,0% nelle donne brasiliane anziane.
Entrate e previsioni del mercato del trattamento della sarcopenia del Sud e America centrale fino al 2030 (milioni di dollari)
Segmentazione del mercato del trattamento della sarcopenia del Sud e America centrale
Il trattamento della sarcopenia del Sud e America centrale il mercato è classificato in tipo di trattamento, canale di distribuzione e paese.
In base al tipo di trattamento, il mercato del trattamento della sarcopenia del Sud e Centro America è segmentato in integratore di vitamina D e calcio, integratore proteico, integratore di vitamina B12 e altri. Il segmento degli integratori di vitamina D e calcio ha detenuto la maggiore quota di mercato del trattamento della sarcopenia in Sud e Centro America nel 2022.
In termini di canale di distribuzione, il mercato del trattamento della sarcopenia in Sud e Centro America è segmentato in farmacie, canali di vendita al dettaglio, online canali e altri. Il segmento delle farmacie deteneva la maggiore quota di mercato del trattamento della sarcopenia dell\'America meridionale e centrale nel 2022.
Per paese, il mercato del trattamento della sarcopenia dell\'America meridionale e centrale è segmentato in Brasile, Argentina e il resto dell\'America meridionale e centrale. Il Brasile ha dominato la quota di mercato del trattamento della sarcopenia in Sud e Centro America nel 2022.
Abbott Laboratories, Bayer AG, Nestlé Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp e GSK Plc sono alcuni dei aziende leader che operano nel mercato del trattamento della sarcopenia del Sud e Centro America.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
4.1 South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - South & Central America Market Analysis
5.1 South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020- 2030
5.2 South & Central America Sarcopenia Treatment Market Forecast and Analysis
6. South & Central America Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Sarcopenia Treatment Market - Country Analysis
8.1 South & Central America
8.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 Rest of South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Nestle Health Science SA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novartis AG
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Pfizer Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Sanofi SA
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Amway Corp
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 GSK Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. South & Central America Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 14. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 15. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. South & Central America Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. South & Central America Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. South & Central America Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. South & Central America Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. South & Central America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Nestle Health Science SA
4. Novartis AG
5. Pfizer Inc
6. Sanofi SA
7. Amway Corp
8. GSK Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.